PRESS-RELEASE filed Aug 27, 2026 at 08:00 ET
HealthEquity reported Q2 FY2027 revenue of $350.7M (+8% YoY) and non-GAAP EPS of $1.24, beating consensus estimates of $349.2M and $1.19 respectively. The company raised its full-year revenue guidance to $1.411B-$1.421B and non-GAAP EPS to $4.66-$4.73, driven by record HSA accounts (10.7M) and assets ($37.9B), with Adjusted EBITDA margin expanding to 48%. The beat and raised guidance signal strong operational momentum and durable growth in the HSA business.